Trastuzumab

CAS 180288-69-1Biologic

Overview

Trastuzumab is a monoclonal antibody used as a targeted therapy for certain types of breast cancer that are HER2-positive. It works by binding to the HER2 receptor on cancer cells, inhibiting their growth and survival.

Therapeutic areas

OncologyBreast CancerGastroesophageal Cancer
Verified Supplier Partner

Do you supply Trastuzumab? Get in front of buyers actively sourcing it.

We route real sourcing requests from pharma buyers to vetted, verified partners — qualified leads, not just a listing. Tell us what you make and we'll be in touch about becoming a Verified Supplier Partner.

No cost to enquire · we only reach out with a fit.

Related APIs

Paclitaxel
29 suppliers
Palbociclib
24 suppliers
Abemaciclib
15 suppliers
Exemestane
15 suppliers
Fulvestrant
14 suppliers
Capecitabine
25 suppliers
Anastrozole
25 suppliers
Deferasirox
24 suppliers

Ready to Accelerate Your
Discovery Workflow?

Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 7 days.

Start free trialBook a demo